Back to company

15-Bio ApS: Financial statements 2023

CVR: 39889277

15-Bio ApS (CVR 39889277) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -5,001 and a net result of DKK -5,001 compared with DKK -3,577 the year before. Equity amounted to DKK 26,548. The solvency ratio was 59.2%.

Gross Profit
-5,001 kr.
Profit/Loss
-5,001 kr.
Equity
26,548 kr.
Total Assets
44,831 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023--5 t.-5 t.27 t.-
2022--5 t.-4 t.32 t.-
2021--6 t.-7 t.35 t.-
2020--1 t.-1 t.42 t.-
2019--13 t.-22 t.43 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

15-Bio ApS: The 2022 annual report is outMay 9, 2023

15-Bio ApS has published its annual report for 2022. Gross profit came to DKK -5,169, and the net result was DKK -3,577.

About 15-Bio ApS

15-Bio ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Rasmus Jorgensen Holdings ApS and Rasmus Jorgensen IVS. The management consists of Rasmus Jørgensen. The company is owned by Rasmus Jørgensen. In 2025, the company reported a gross profit of DKK -6,875 and a net result of DKK -6,875 compared with DKK -8,126 the year before. Equity amounted to DKK 11,547.

Other financial years